Pilvi Maliniemi
R&d
Helsinki, Finland
Helsinki, Finland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Using the Jurkat reporter T cell line for evaluating the functionality of novel chimeric antigen receptors.
Journal: Frontiers in molecular medicine
Published: October 14, 2022
Novel modular chimeric antigen receptor spacer for T cells derived from signal regulatory protein alpha Ig-like domains.
Journal: Frontiers in molecular medicine
Published: September 20, 2022
Tumour Suppressor Neuron Navigator 3 and Matrix Metalloproteinase 14 are Co-expressed in Most Melanomas but Downregulated in Thick Tumours.
Journal: Acta dermato-venereologica
Published: October 07, 2021
RUNX1 mutations in blast-phase chronic myeloid leukemia associate with distinct phenotypes, transcriptional profiles, and drug responses.
Journal: Leukemia
Published: May 16, 2020
Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion.
Journal: Cytotherapy
Published: June 25, 2017
Low interleukin-2 concentration favors generation of early memory T cells over effector phenotypes during chimeric antigen receptor T-cell expansion.
Journal: Cytotherapy
Published: December 12, 2016
Molecular characterization of subcutaneous panniculitis-like T-cell lymphoma reveals upregulation of immunosuppression- and autoimmunity-associated genes.
Journal: Orphanet journal of rare diseases
Published: January 01, 2014
Expression of human endogenous retrovirus-w including syncytin-1 in cutaneous T-cell lymphoma.
Journal: PloS one
Published: June 04, 2013
Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis.
Journal: Genes, chromosomes & cancer
Published: June 18, 2012
Last Updated: 09/26/2026